By Emily Burke, Ph.D., Director of Instruction, BiotechPrimer.com  |  Nov 4, 2015

Targeting Breast Cancer: The Subtypes of Breast Cancer

Editor’s Note: Based on an article originally published in Biotech Primer Weekly. Hearing your doctor utter the words HER2-positive, HR-positive, triple-negative or BRCA mutation can be devastating — even for the most resilient person. Simply put, all are linked to breast cancer. Breast cancer is complex, and a diagnosis can…more.

Close menu